VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
1.05
0.05 (5.00%)
At close: May 23, 2025, 3:59 PM
1.06
1.31%
After-hours: May 23, 2025, 05:25 PM EDT
VYNE Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 501K |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.27M | 3.17M | 2.96M | 3.29M | 3.77M | 3.88M | 3.03M | 3.22M | 3.24M | 3.71M | 3.95M | 4.3M | 4.42M | 8.2M | 13.83M | 15.84M | 16.62M | 17.9M | 19.77M | 26.46M | 25.41M | 10.17M | 4.8M | 3.76M | 3.75M | 3.36M | 3.04M | 3.09M | 2.7M | 1.71M | 1.24M | 1.21M | 1.01M | 1.3M | 845K |
| Selling, General, and Administrative Revenue Growth | +3.31% | +6.95% | -9.85% | -12.79% | -2.96% | +28.22% | -5.90% | -0.62% | -12.69% | -6.15% | -8.15% | -2.54% | -46.12% | -40.73% | -12.65% | -4.70% | -7.19% | -9.43% | -25.30% | +4.11% | +149.83% | +111.76% | +27.80% | +0.35% | +11.36% | +10.84% | -1.78% | +14.57% | +58.09% | +38.03% | +1.81% | +19.96% | -22.03% | +53.61% | n/a |
| Research and Development Revenue | 6.12M | 9.68M | 10.25M | 7.31M | 3.71M | 3.02M | 3.32M | 7.23M | 2.73M | 4.28M | 5.55M | 4.11M | 4.45M | 5.24M | 6.98M | 6.41M | 6.33M | 7.84M | 6.62M | 13.12M | 15.95M | 11.76M | 12.62M | 13.46M | 15.92M | 15.08M | 10.67M | 16.23M | 11.02M | 10.55M | 8.01M | 5.46M | 4.99M | 4.08M | 2.85M |
| Research and Development Revenue Growth | -36.76% | -5.50% | +40.27% | +97.03% | +22.66% | -8.89% | -54.13% | +164.56% | -36.11% | -22.85% | +35.00% | -7.73% | -14.96% | -25.01% | +8.92% | +1.20% | -19.20% | +18.35% | -49.52% | -17.76% | +35.68% | -6.85% | -6.20% | -15.49% | +5.62% | +41.33% | -34.26% | +47.24% | +4.49% | +31.69% | +46.67% | +9.38% | +22.44% | +42.95% | n/a |